Growth Metrics

Labcorp Holdings (LH) Liabilities and Shareholders Equity (2016 - 2026)

Labcorp Holdings' Liabilities and Shareholders Equity history spans 18 years, with the latest figure at $19.1 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 8.43% to $19.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $73.8 billion, a 3.5% increase, with the full-year FY2025 number at $18.4 billion, changed 0.07% from a year prior.
  • Liabilities and Shareholders Equity hit $19.1 billion in Q1 2026 for Labcorp Holdings, up from $18.4 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for LH hit a ceiling of $20.7 billion in Q1 2022 and a floor of $16.5 billion in Q1 2024.
  • Historically, Liabilities and Shareholders Equity has averaged $18.5 billion across 5 years, with a median of $18.4 billion in 2024.
  • The widest YoY moves for Liabilities and Shareholders Equity: up 10.22% in 2024, down 18.16% in 2024.
  • Tracing LH's Liabilities and Shareholders Equity over 5 years: stood at $20.2 billion in 2022, then fell by 17.02% to $16.7 billion in 2023, then increased by 9.89% to $18.4 billion in 2024, then grew by 0.07% to $18.4 billion in 2025, then grew by 3.78% to $19.1 billion in 2026.
  • Business Quant data shows Liabilities and Shareholders Equity for LH at $19.1 billion in Q1 2026, $18.4 billion in Q4 2025, and $18.3 billion in Q3 2025.